Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
12
TGA:12
Drug Approvals
VOXZOGO vosoritide 0.56 mg powder for injection vial and diluent pre-filled syringe (376617)
- Product Name
- VOXZOGO vosoritide 0.56 mg powder for injection vial and diluent pre-filled syringe
- Approval Date
- Jul 6, 2022
TGA
VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe (376618)
- Product Name
- VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe
- Approval Date
- Jul 6, 2022
TGA
VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe (376616)
- Product Name
- VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe
- Approval Date
- Jul 6, 2022
TGA
PALYNZIQ pegvaliase 10 mg/0.5 mL solution for injection pre-filled syringe (341754)
- Product Name
- PALYNZIQ pegvaliase 10 mg/0.5 mL solution for injection pre-filled syringe
- Approval Date
- Jul 14, 2021
TGA
PALYNZIQ pegvaliase 2.5 mg/0.5 mL solution for injection pre-filled syringe (341753)
- Product Name
- PALYNZIQ pegvaliase 2.5 mg/0.5 mL solution for injection pre-filled syringe
- Approval Date
- Jul 14, 2021
TGA
PALYNZIQ pegvaliase 20 mg/mL solution for injection pre-filled syringe (341752)
- Product Name
- PALYNZIQ pegvaliase 20 mg/mL solution for injection pre-filled syringe
- Approval Date
- Jul 14, 2021
TGA
KUVAN sapropterin dihydrochloride 500 mg oral powder sachet (297734)
- Product Name
- KUVAN sapropterin dihydrochloride 500 mg oral powder sachet
- Approval Date
- Dec 13, 2018
TGA
KUVAN sapropterin dihydrochloride 100 mg oral powder sachet (297728)
- Product Name
- KUVAN sapropterin dihydrochloride 100 mg oral powder sachet
- Approval Date
- Dec 13, 2018
TGA
BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial (298672)
- Product Name
- BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial
- Approval Date
- Aug 28, 2018
TGA
VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial (215523)
- Product Name
- VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial
- Approval Date
- Dec 9, 2014
TGA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found